GCTK · Glucotrack, Inc. · Financials
$1.16
-0.05 (-4.13%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based upon this review and our current financial condition, we have concluded that substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.28M
Shares
705,255
Volume · Oct 2
301.42K
Avg daily vol (24 sessions)
3.59M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$208K
-100%
FY2019
Net Income
-$19.39M
+14.2%
FY2025
Operating Margin
1685.58%
+1685.6pp
FY2019
Diluted EPS
$468.30
-99.2%
FY2025
Operating Cash Flow
-$15.24M
-22%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $70.02K | — | — | — | — | — | — | $208K | $17B | $589.46K | $611.69K | $143.17K | $59.78K | — | — | — | — | — | — | — | — | — | — | — | |
| $125.18K | — | — | — | — | — | — | $43 | $18.29K | $24.4K | -$16.22K | -$15.21K | $2189 | — | — | — | — | — | — | — | — | — | — | — | |
| $8.94M | $9.81M | $9.5M | $4.7M | $1.97M | $1.81M | $1.53M | $1.61M | $3.03M | $3.21M | $2.88M | $2.27M | $1.85M | $1.99M | $1.92M | $1.79M | $934.06K | $1.01M | — | — | — | — | — | — | |
| — | — | — | $122K | — | $139K | $415K | $573K | $1.09M | $1.53M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $6.46M | $6.28M | $5.05M | $2.28M | $2.47M | $2.09M | $1.19M | $1.54M | $2.46M | $6.43M | $2.26M | $1.4M | $1.59M | $1.04M | $852.91K | $544.15K | $457.5K | $165.16K | — | — | — | — | — | — | |
| — | — | — | — | — | $139K | $415K | — | — | $1.53M | $1.13M | $1.13M | $230.76K | $1.04M | $852.91K | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $32K | $32K | — | — | — | — | — | — | — | $25.55K | $22.84K | $53.22K | — | — | — | — | — | — | — | |
| $15.4M | $16.09M | $14.55M | $7.1M | $4.43M | $4.04M | $3.13M | $3.71M | $6.58M | $11.17M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | $11.17M | $6.27M | $4.8M | $3.67M | $3.03M | $2.77M | — | — | — | — | — | — | — | — | — | |
| -$15.4M | -$16.09M | -$14.55M | -$7.1M | -$4.43M | -$4.04M | -$3.13M | $3.51M | -$6.54M | $10.58M | -$5.66M | -$4.66M | -$3.61M | -$3.03M | -$2.77M | -$2.33M | -$1.39M | -$1.17M | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | 1685.58% | -0.04% | 1794.15% | -924.63% | -3251.69% | -6034.9% | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | -$4.01M | -$3.1M | — | — | — | — | — | — | — | -$2.75M | -$2.31M | -$1.34M | — | — | — | — | — | — | — | |
| — | — | $44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$412K | -$3.3M | -$8.05M | — | -$14K | -$53K | $338K | -$10.52K | -$176.82K | $247.05K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$2.7M | -$3.52M | -$6.72M | -$10.33M | -$5.41M | -$5.84M | $2.98M | -$9.8M | -$2.77M | -$2.36M | -$2.79M | — | — | — | — | — | — | — | |
| -$15.95M | -$19.39M | -$22.6M | -$7.1M | -$4.44M | -$4.07M | -$2.7M | $3.52M | -$6.72M | $10.33M | -$5.41M | -$5.84M | $2.98M | -$9.8M | -$2.77M | -$2.36M | -$2.79M | -$1.2M | -$1.53M | -$1.59M | -$1.28M | -$1.06M | -$288.23K | -$350.29K | |
| — | — | — | — | — | — | — | 1690.38% | -0.04% | 1752.24% | -884.39% | -4080.67% | 4986.07% | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | -$22.6M | -$7.95M | $4.44M | — | -$2.7M | -$3.52M | -$39.82M | -$11.76M | -$6.23M | -$6.29M | $1.97M | -$10.36M | -$2.77M | -$2.36M | — | — | — | — | — | — | — | — | |
| -$15.95M | -$19.34M | -$22.57M | -$7.1M | -$4.41M | $4.09M | -$2.81M | $3.56M | -$6.66M | $10.28M | -$5.44M | -$5.82M | $2.99M | -$9.75M | -$2.76M | -$2.4M | -$2.67M | — | — | — | — | — | — | — | |
| USD/shares | -$226.95 | $468.30 | $61,590.00 | $30,762.00 | $26,100.00 | $23,400.00 | -$23,400.00 | -$23,400.00 | -$5,545,800.00 | -$2,187,900.00 | -$1,263,600.00 | -$1,345,500.00 | $432,900.00 | -$2,281,500.00 | -$608,400.00 | — | — | — | — | — | — | — | — | — |
| USD/shares | -$226.95 | $468.30 | $61,590.00 | $30,762.00 | $26,100.00 | $23,400.00 | $17,100.00 | -$23,400.00 | -$5,545,800.00 | -$2,187,900.00 | -$1,263,600.00 | -$1,345,500.00 | $432,900.00 | -$2,281,500.00 | -$608,400.00 | — | — | — | — | — | — | — | — | — |
| shares | — | 41.41K | 366.8667 | 230.67 | 171.94 | 171.6758 | 167.5465 | 132.418 | 7.1768 | 5.3721 | 4.9477 | 4.6811 | 4.5338 | 4.5519 | 4.5426 | 4.3516 | 3.4485 | — | — | — | — | — | — | — |
| shares | — | 41.41K | 366.8667 | 230.67 | 171.94 | 171.68K | 167.5465 | 132.418 | 7.1768 | 5.3721 | 4.9477 | 4.6811 | 4.572 | 4.5519 | 4.5426 | 4.3516 | 3.4485 | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 19,000 | 10-Q filed 2026-08-14 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 0.68×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 38 similar-size Medical Devices companies (of 150 listed).